Basel Medical (BMGL) Equity Ratio (2024 - 2025)

Basel Medical recorded quarterly Equity Ratio of 0.29 in Q2 2025, down 37.21% quarter-over-quarter from 0.46 in Q2 2024, and down 37.21% year-over-year from 0.46 in Q2 2024.

Basel Medical's Equity Ratio history runs 2 years deep, the most recent figure standing at 0.29 for Q2 2025.

  • In Q2 2025, Equity Ratio fell 37.21% year-over-year to 0.29; the TTM figure through Jun 2025 stood at 0.29 (down 37.21% YoY), while the FY2025 annual figure was 0.29, down 37.21% from the prior year.
  • Equity Ratio came in at 0.29 for Q2 2025 at Basel Medical, down from 0.46 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.46 in Q2 2024 to a low of 0.29 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -0.05
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 0.15
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn -0.03
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 0.45
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 0.42
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 0.48
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 0.43
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 0.55
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn 0.18
10 Basel Medical 8.57 Mn 6.23 Mn - 0.29

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 0.29
Jun 30, 2024 0.46